Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Pre-Conference Ticketed Event

APA Award Winner

APS Award Winner

ASPN Award Winner

SPR Award Winner

On Demand Presentation

Poster Icons

SPR Award Winner

Back

183 Views

Evaluation ViewAttendees 16

Academic and Research Skills

Advocacy

Allergy, Immunology and Rheumatology

Basic Science

Children with Chronic Conditions

Clinical Research

Community Pediatrics

Developmental and Behavioral Pediatrics

Epidemiology

General Pediatrics

Hospital Medicine

Infectious Diseases

Neonatology

Public Health

Quality Improvement/Patient Safety

Well Newborn

Session: Should We Be Adding Congenital CMV to the Universal Newborn Screening Panel? Advocacy, Policy, Progress and Controversy.

Updated Recommendations on cCMV Diagnosis and Management: How Will the AAP COID Statement Address Universal cCMV Screening?

Monday, May 6, 2024

2:08 PM – 2:27 PM ET

Location: Metro Toronto Convention Centre: 106

Speaker(s)

Mary T. Caserta, MD (she/her/hers)
Professor of Pediatrics, Division of Pediatric Infectious Diseases, part-time
University of Rochester Medical Center
Rochester, New York, United States

Disclosure(s):

Mary T. Caserta, MD: Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)